In-person Event: Defensive Growth: Investing in Healthcare and Life Science Innovation

About the Event

Defensive Growth: Investing in Healthcare and Life Science Innovation

In an era where innovation is the key to advancement, the healthcare and life sciences sector stands at the forefront of transformative change, especially under the backdrop of a globally aging population that drives scientific acceleration and investments in digital health, biotech, pharmaceutical innovation and more.

Endowus, in partnership with Janus Henderson Investors, a leading global fund manager with over US$300 billion of assets under management is excited to present this exclusive event designed for investors to explore the dynamic and rapidly evolving landscape of the healthcare sector, which is known for its capabilities to combine both defensive with opportunistic growth to investors’ portfolios.

Join us on May 29, 2024 (Wednesday) from 6:30-8:30pm for a session with Hugh Chung, Endowus Chief Investment Advisory Officer and Andrew Cox, Equities Investment Specialist from Janus Henderson Investors where the two experts will explore the global market trends and share their wealth of experience in how to strategically approach the latest trends, risk-return profile and unique investment opportunities in the healthcare industry.

Event Information

Date: Wednesday, 29th May 2024
Time: 6.30pm - 8.30pm  (registration begins at 6pm)
‍Venue: The Executive Centre, 19/F, Two Chinachem Central, 26 Des Voeux Road, Central, Hong Kong

The event may qualify for 1 hour of Continuous Professional Training (CPT) under the Hong Kong Securities and Futures Commission guidelines subject to your employer or internal compliance approval. An attendance letter can be requested and will be issued 7 business days after the event. A minimum participation time of 50 minutes is required to receive credit.

About the speakers

Andrew Cox, CFA, Investment Specialist, Equity, Janus Henderson Investors

Andrew Cox is an Equities Investment Specialist at Janus Henderson Investors. He is responsible for representing the firm’s suite of equity products to investors. Since starting his career in 2001, Andrew has been an equity portfolio manager at Schroders, GIC and EII Capital in London and New York, as well as a sell-side equity research analyst. Andrew is a CFA Charterholder and earned a degree in economics from the University of St Andrews.

Hugh Chung, Chief Investment Advisory Officer, Endowus

Hugh Chung is the Chief Investment Advisory Officer at Endowus, Asia’s leading digital wealth platform. 

In his current role, Hugh leads the integration of investment functions and strategies across the Endowus Group, comprising the Endowus digital platform, Endowus Private Wealth, and Carret Private. He oversees the centralised Investment Office, which provides group strategic direction on the expert curation and management of all investment solutions across public and private markets, for individual and institutional investors in Singapore and Hong Kong. 

Hugh has more than 20 years of experience in the asset management and financial advisory space in Asia. In his previous role as the Chief Investment Officer for a single family office, he was responsible for strategic asset allocation, portfolio construction and fund selection across all regions and asset classes. Hugh was also previously Managing Director at Kadensa Capital and Azentus Capital as the founding member and senior investor of two of the most successful hedge fund launches in Asia. Before this, Hugh had oversight of Korea equity distribution at J.P. Morgan, and began his career at Goldman Sachs and Samsung Securities.

‍

<divider><divider>

‍

Risk Warnings

Investment involves risk. Past performance is not an indicator nor a guarantee of future performance or returns. Projected performance or returns is not guaranteed to materialise. The value of investments and the income from them can go down as well as up, and you may not get the full amount you invested.

Rates of exchange may cause the value of investments to go up or down. Individual stock performance does not represent the return of a fund.

General risk warnings relating to collective investment schemes

Before making an investment decision, you are reminded to refer to the relevant prospectus/ offering document for specific risk considerations and related fees and charges.

Funds are not a bank deposit and not capital guaranteed, and is subject to investment risks, including the possible loss of the principal amount invested.  

Some of the funds also involve derivatives. Do not invest in them unless you fully understand and are willing to assume the risks associated with them.

Opinions

Any forward-looking statements, prediction, projection or forecast on the economy, stock market, bond market or economic trends of the markets contained in this material are subject to market influences and contingent upon matters outside the control of Endowus HK Limited (“Endowus”) and therefore may not be realised in the future. Further, any opinion or estimate is made on a general basis and subject to change without notice. In presenting the information above, none of Endowus HK Limited, its affiliates, directors, employees, representatives or agents have given any consideration to, nor have made any investigation of the objective, financial situation or particular need of any user, reader, any specific person or group of persons. Therefore, no representation is made as to the completeness and adequacy of the information to make an informed decision. You should carefully consider (i) whether any investment views and products/ services are appropriate in view of your investment experience, objectives, financial resources and relevant circumstances. You may also wish to seek financial advice through a financial advisor or the Endowus platform and independent legal, accounting, regulatory or tax advice, as appropriate.

No invitation or solicitation

Nothing contained [in this article] should be construed as a solicitation, an offer to buy or sale, or recommendation, to acquire or dispose of any security, commodity, investment or to engage in any other transaction in any jurisdiction in which such solicitation, offer to buy or sale would be unlawful under the securities laws in such jurisdiction. No information included [on this website/ in this article] is to be construed as investment advice or as a recommendation or a representation about the suitability or appropriateness of any advisory product or service; or an offer to buy or sell, or the solicitation of an offer to buy or sell, any security, financial product, or instrument; or to participate in any particular trading strategy. Investors should seek independent financial and tax advice before making any investment decision.

‍